Blue water vaccines to present update on novel, live attenuated, intranasally delivered streptococcus pneumoniae vaccine to prevent acute otitis media, pneumococcal pneumonia, and invasive pneumococcal disease at the world vaccine & immunotherapy congress west coast 2022

Cincinnati, dec. 01, 2022 (globe newswire) -- blue water vaccines inc. (“bwv” or “blue water vaccines” or the “company”), today announced that ali fattom, ph.d., will present at the world vaccine & immunotherapy congress west coast 2022 in san diego, california on thursday, december 1, 2022. dr. fattom will present an overview and current progress of bwv-201, a live attenuated, intranasally delivered, serotype independent streptococcus pneumoniae vaccine candidate for the prevention of acute otitis media (“aom”), pneumococcal pneumonia, and invasive pneumococcal disease.
BWV Ratings Summary
BWV Quant Ranking